West Pharma vs Charles River
Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.
Snapshot comparison (2026-08-28)
| WST | CRL | |
|---|---|---|
| Company | West Pharma | Charles River |
| Market | 🇺🇸 US | 🇺🇸 US |
| Sector | Healthcare | Healthcare |
| Price | $349.92 | $296.41 |
| Signal | LONG · +60.1% | LONG · +62.8% |
| Total return | +60.1% | +59.5% |
Decide it with the calculator
Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.
Open both briefs
Run it on live data — free
Stock Chat + Screener preview · 30 monthly AI credits. Real-time scanner across US, Hong Kong, China A-shares, Korea, and India.
FAQ
West Pharma or Charles River — which is the better buy?
The honest answer comes from the same workflow on both names: quality score, valuation ceiling versus today's price, and which thesis breaks worry you more. The snapshot table above gives the current dated state of each.
How are WST and CRL different?
West Pharma trades on US (Healthcare); Charles River trades on US (Healthcare). Currency, liquidity, and disclosure regimes differ — the workflow stays identical.
Get more Balance Labs in your Google results
Add balancelabs.app as a Preferred Source on Google to see our research in Search and AI Overviews.
← All guides · Home · Data snapshot 2026-08-28 · Not investment advice.